Disc Medicine
IRON • NASDAQ
Disc Medicine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John D. Quisel, with a market cap of $2.6B.
Market Cap$2.6B
Employees74.0
CEOJohn D. Quisel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Disc Medicine FAQ
Common questions about Disc Medicine
Disc Medicine is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open. Analysts estimate revenue of $437.5K.
Disc Medicine has approximately 74 employees.